Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Recruiting 4Unknown 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 1Sleep Initiation and Maintenance Disorders 1Neoplasms 1Melanoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Depression 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Cognitive Behavioral Therapy × Clear all
NCT02410564 2016-02-10

CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients

Virginia Commonwealth University

Phase NA Terminated
29 enrolled

Sleep Initiation and Maintenance Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡